XF6-26512-57136 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-07-03
Registered in v-safe
2021-07-03
Dose 1 — Pfizer-BioNTech
2021-07-03
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea

Adult check-in
2021-07-04
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-07-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-07-13
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-07-24
Dose 2 — Pfizer-BioNTech
2021-07-24
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · None

Adult check-in
2021-07-25
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-07-26
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-07-29
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-08-01
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-08-07
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-08-28
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-09-07
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2022-01-22
Survey response — 6 months, dose 2
MedDRA: Chills, Dizziness, Injection site erythema, Injection site swelling — Feeling: Fair · Be unable to do your normal daily activities

Free text: Dizzy chill injection site redness and swelling

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-07-03	Pfizer-BioNTech	No
2	2021-07-24	Pfizer-BioNTech	No

Free text

Release 11 — 6 months, dose 2

2022-01-22

Symptoms: Dizzy chill injection site redness and swelling

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Chills	·	·	✓
SD	Dizziness	·	·	✓
SD	Injection site erythema	·	·	✓
SD	Injection site swelling	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release